News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,678 Results
Type
Article (87854)
Company Profile (824)
Press Release (779985)
Multimedia
Podcasts (190)
Webinars (28)
Section
Business (233204)
Career Advice (4144)
Deals (39859)
Drug Delivery (145)
Drug Development (91392)
Employer Resources (203)
FDA (18373)
Job Trends (17416)
News (397804)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (179)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (326)
Approvals (18530)
Artificial intelligence (603)
Autoimmune disease (148)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (156)
Brain cancer (63)
Breast cancer (639)
Cancer (4865)
Cardiovascular disease (427)
Career advice (3566)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (807)
Cervical cancer (37)
Clinical research (76827)
Collaboration (1705)
Company closure (5)
Compensation (1115)
Complete response letters (69)
COVID-19 (2984)
CRISPR (95)
C-suite (809)
Cystic fibrosis (152)
Data (6088)
Decentralized trials (2)
Denatured (70)
Depression (139)
Diabetes (518)
Diagnostics (7199)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (292)
Drug pricing (214)
Drug shortages (36)
Duchenne muscular dystrophy (231)
Earnings (99958)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134883)
Executive appointments (1019)
FDA (21396)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (24)
Funding (1508)
Gene editing (206)
Generative AI (62)
Gene therapy (650)
GLP-1 (1103)
Government (5431)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (58)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (285)
Immuno-oncology (48)
Indications (80)
Infectious disease (3264)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (233)
Interviews (816)
IPO (17950)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (663)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (797)
MASH (171)
Medical device (14996)
Medtech (15040)
Mergers & acquisitions (22933)
Metabolic disorders (1349)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (336)
Neuropsychiatric disorders (92)
Neuroscience (3047)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (649)
Opinion (330)
Ovarian cancer (160)
Pain (196)
Pancreatic cancer (221)
Parkinson's disease (288)
Partnered (38)
Patents (486)
Patient recruitment (447)
Peanut (60)
People (66776)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23739)
Phase II (33333)
Phase III (25133)
Pipeline (4464)
Policy (326)
Postmarket research (3554)
Preclinical (10679)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (847)
Real estate (7437)
Recruiting (80)
Regulatory (28792)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (26)
RNA editing (17)
RSV (82)
Schizophrenia (157)
Series A (252)
Series B (187)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4332)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1122)
Venture capital (91)
Weight loss (447)
Women's health (82)
Worklife (21)
Date
Today (34)
Last 7 days (916)
Last 30 days (1904)
Last 365 days (33208)
2026 (989)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (87)
Alaska (7)
Arizona (336)
Arkansas (14)
Asia (51453)
Australia (9031)
California (11185)
Canada (3237)
China (1112)
Colorado (469)
Connecticut (488)
Delaware (338)
Europe (118230)
Florida (1639)
Georgia (356)
Hawaii (3)
Idaho (68)
Illinois (929)
India (64)
Indiana (530)
Iowa (23)
Japan (408)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1428)
Massachusetts (8297)
Michigan (348)
Minnesota (643)
Mississippi (6)
Missouri (136)
Montana (35)
Nebraska (28)
Nevada (121)
New Hampshire (83)
New Jersey (3042)
New Mexico (33)
New York (2973)
North Carolina (1572)
North Dakota (10)
Northern California (5316)
Ohio (342)
Oklahoma (22)
Oregon (54)
Pennsylvania (2249)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4304)
Tennessee (172)
Texas (1769)
United States (40576)
Utah (335)
Vermont (1)
Virginia (280)
Washington D.C. (85)
Washington State (943)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 868,678 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
January 12, 2026
·
4 min read
Press Releases
Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer
January 12, 2026
·
19 min read
Press Releases
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 9, 2026
January 12, 2026
·
5 min read
Press Releases
RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
January 12, 2026
·
36 min read
Press Releases
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
January 12, 2026
·
10 min read
Press Releases
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
January 12, 2026
·
2 min read
Press Releases
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
10 min read
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 9, 2026
January 12, 2026
·
1 min read
Press Releases
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
January 12, 2026
·
9 min read
Press Releases
Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
January 12, 2026
·
4 min read
1 of 86,868
Next
